Regarding the role of POLE mutations in endometrial cancer, most studies are focused on the association of POLE mutations with clinical outcomes and antitumor immune responses, and only a few studies investigated the role of POLE mutations in chemoresistance (19, 20). This evidence concerns the gene POLE and endometrial cancer.